|
1
|
Todd R, McBride J, Tsuji T, et al: Deleted
in oral cancer-1 (doc-1), a novel oral tumor suppressor gene. FASEB
J. 9:1362–1370. 1995.PubMed/NCBI
|
|
2
|
Daigo Y, Suzuki K, Maruyama O, et al:
Isolation, mapping and mutation analysis of a human cDNA homologous
to the doc-1 gene of the Chinese hamster, a candidate tumor
suppressor for oral cancer. Genes Chromosomes Cancer. 20:204–207.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tsuji T, Duh FM, Latif F, et al: Cloning,
mapping, expression, function, and mutation analyses of the human
ortholog of the hamster putative tumor suppressor gene Doc-1. J
Biol Chem. 273:6704–6709. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kohno Y, Patel V, Kim Y, et al: Apoptosis,
proliferation and p12(doc-1) profiles in normal, dysplastic and
malignant squamous epithelium of the Syrian hamster cheek pouch
model. Oral Oncol. 38:274–280. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rosenblatt J, Gu Y and Morgan DO: Human
cyclin-dependent kinase 2 is activated during the S and G2 phases
of the cell cycle and associates with cyclin A. Proc Natl Acad Sci
USA. 89:2824–2828. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Matsuo K, Shintani S, Tsuji T, et al:
p12(DOC-1), a growth suppressor, associates with DNA polymerase
alpha/primase. FASEB J. 14:1318–1324. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zheng J, Xue H, Wang T, et al: miR-21
downregulates the tumor suppressor P12 CDK2AP1 and stimulates cell
proliferation and invasion. J Cell Biochem. 112:872–880. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Deshpande AM, Dai YS, Kim Y, et al:
Cdk2ap1 is required for epigenetic silencing of Oct4 during murine
embryonic stem cell differentiation. J Biol Chem. 284:6043–6047.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tsuji T, Ibaragi S, Shima K, et al:
Epithelial-mesenchymal transition induced by growth suppressor
p12CDK2-AP1 promotes tumor cell local invasion but suppresses
distant colony growth. Cancer Res. 68:10377–10386. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cwikla SJ, Tsuji T, McBride J, Wong DT and
Todd R: doc-1-mediated apoptosis in malignant hamster oral
keratinocytes. J Oral Maxillofac Surg. 58:406–414. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tao K, Fang M, Alroy J and Sahagian GG:
Imagable 4T1 model for the study of late stage breast cancer. BMC
Cancer. 8:2282008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hiyoshi Y, Watanabe M, Hirashima K, et al:
p12CDK2-AP1 is associated with tumor progression and a poor
prognosis in esophageal squamous cell carcinoma. Oncol Rep.
22:35–39. 2009.PubMed/NCBI
|
|
13
|
Choi MG, Sohn TS, Park SB, et al:
Decreased expression of p12 is associated with more advanced tumor
invasion in human gastric cancer tissues. Eur Surg Res. 42:223–229.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shin J, Yuan Z, Sreeramoju P, et al: A del
T poly T (8) mutation in the 3′ untranslated region (UTR) of the
CDK2-AP1 gene is functionally significant causing decreased mRNA
stability resulting in decreased CDK2-AP1 expression in human
microsatellite unstable (MSI) colorectal cancer (CRC). Surgery.
142:222–227. 2007.PubMed/NCBI
|
|
15
|
Zolochevska O and Figueiredo ML:
Cell-cycle regulators cdk2ap1 and bicalutamide suppress malignant
biological interactions between prostate cancer and bone cells.
Prostate. 71:353–367. 2011. View Article : Google Scholar
|
|
16
|
Figueiredo ML, Kim Y, St John MA and Wong
DT: p12CDK2-AP1 gene therapy strategy inhibits tumor growth in an
in vivo mouse model of head and neck cancer. Clin Cancer Res.
11:3939–3948. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kar G, Gursoy A and Keskin O: Human cancer
protein-protein interaction network: a structural perspective. PLoS
Comput Biol. 5:e10006012009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Buajeeb W, Zhang X, Ohyama H, et al:
Interaction of the CDK2-associated protein-1, p12(DOC-1/CDK2AP1),
with its homolog, p14(DOC-1R). Biochem Biophys Res Commun.
315:998–1003. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shintani S, Ohyama H, Zhang X, et al:
p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein.
Mol Cell Biol. 20:6300–6307. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bonetta L: Protein-protein interactions:
Interactome under construction. Nature. 468:851–854. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bock C, Reither S, Mikeska T, Paulsen M,
Walter J and Lengauer T: BiQ Analyzer: visualization and quality
control for DNA methylation data from bisulfite sequencing.
Bioinformatics. 21:4067–4068. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Le Guezennec X, Vermeulen M, Brinkman AB,
et al: MBD2/NuRD and MBD3/NuRD, two distinct complexes with
different biochemical and functional properties. Mol Cell Biol.
26:843–851. 2006.PubMed/NCBI
|
|
23
|
Spruijt CG, Bartels SJ, Brinkman AB, et
al: CDK2AP1/DOC-1 is a bona fide subunit of the Mi-2/NuRD complex.
Mol Biosyst. 6:1700–1706. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yochum GS and Ayer DE: Role for the
mortality factors MORF4, MRGX, and MRG15 in transcriptional
repression via associations with Pf1, mSin3A, and Transducin-Like
Enhancer of Split. Mol Cell Biol. 22:7868–7876. 2002. View Article : Google Scholar
|
|
25
|
Peng H, Shintani S, Kim Y and Wong DT:
Loss of p12CDK2-AP1 expression in human oral squamous cell
carcinoma with disrupted transforming growth factor-beta-Smad
signaling pathway. Neoplasia. 8:1028–1036. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Marques RB, Dits NF, Erkens-Schulze S, van
Ijcken WF, van Weerden WM and Jenster G: Modulation of androgen
receptor signaling in hormonal therapy-resistant prostate cancer
cell lines. PLoS One. 6:e231442011. View Article : Google Scholar : PubMed/NCBI
|
